Rasha Adel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rasha Adel has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Assem Mohamed El-Shazly
Department of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Egypt
2 shared publications - Malak Dmirieh
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany
2 shared publications - Mansour Sobeh
AgroBioSciences Research Division, Mohammed VI Polytechnic University, Lot 660–Hay MoulayRachid, Ben-Guerir 43150, Morocco
2 shared publications - Michael Wink
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, 69120 Heidelberg, Germany
2 shared publications - Mona Fouad Mahmoud
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt
2 shared publications - Omar M. Sabry
Department of Pharmacognosy, College of Pharmacy, Cairo University, Cairo 11562, Egypt
2 shared publications
Latest Publications
- Open Access
Correction: Sobeh et al. HPLC-PDA-MS/MS Characterization of Bioactive Secondary Metabolites from Turraea fischeri Bark Extract and Its Antioxidant and Hepatoprotective Activities In Vivo. Molecules 2017, 22, 2089
The authors wish to emphasize that the experiments were simultaneously conducted with several plant species, and identical control groups were utilized for both articles (Phytomedicine (2017), doi:10
Open AccessCorrection: Sobeh et al. HPLC-PDA-MS/MS Characterization of Bioactive Secondary Metabolites from Turraea fischeri Bark Extract and Its Antioxidant and Hepatoprotective Activities In Vivo. Molecules 2017, 22, 2089
The authors wish to emphasize that the experiments were simultaneously conducted with several plant species, and identical control groups were utilized for both articles (Phytomedicine (2017), doi:10
- 26 March 2024
- Published by Springer Nature in Chemistry of Natural Compounds
- Vol. 60 (2) , 263-270
New Hopanoid, Chemical Profiling Using UPLC-ESI-MS/MS and Biological Activities of Centaurea pumilio
- 26 March 2024
- Published by Springer Nature in Chemistry of Natural Compounds
- Vol. 60 (2) , 263-270
New Hopanoid, Chemical Profiling Using UPLC-ESI-MS/MS and Biological Activities of Centaurea pumilio
- Open Access
- 1 December 2022
- Published by Egyptian Knowledge Bank in Zagazig Journal of Pharmaceutical Sciences
- Vol. 31 (2) , 8-21
LC-ESI-MS profile, cytotoxic, antioxidant, insecticidal and antimicrobial activities of wild and in vitro propagated Tanacetum sinaicum Del. ex DC
Tanacetum sinaicum (Asteraceae) is a rare herb growing wild in Southern Sinai mountains in Egypt. The aim of this work was to develop a comparative study between the chemical compositions of the wild plant and the micropropagated one, using HPLC− ESI− MS/MS technique. HPLC- ESI-MS/MS analysis resulted in the identification of 56 compounds including flavonoids, organic acids and their glycosides. Totally, 52 compounds were tentatively identified from the methanolic extracts of wild plant, 10 of them could also be detected in the methanolic extract of the micropropagated plant, in addition to 4 compounds that were detected only in the micropropagated plant. Methanolic extracts of the wild and micropropagated plants showed moderate cytotoxic activity against Hep-G2, HCT-116 and A-549 cell lines using MTT cell viability assay. The antioxidant activity using the DPPH free radical assay was investigated and the results indicated that the wild plant methanolic extract has better antioxidant activity compared to the in vitro plant extract. In addition, the insecticidal activity was measured using the immersion method and the methanolic extract of the micropropagated plant showed a higher mortality percentage than wild plant extract on culex pipiens. Also, results indicate that wild plant extract has mild antimicrobial activity against Gram positive bacteria Staphylococcus aureus and Bacillus subtilis and showed no activity on both fungi and Gram negative bacteria. while in vitro plant extract showed some activity against Gram positive bacteria Staphylococcus aureus and the Gram negative bacteria Escherichia coli.
- 1 December 2022
- Published by Egyptian Knowledge Bank in Zagazig Journal of Pharmaceutical Sciences
- Vol. 31 (2) , 8-21
Open AccessLC-ESI-MS profile, cytotoxic, antioxidant, insecticidal and antimicrobial activities of wild and in vitro propagated Tanacetum sinaicum Del. ex DC
Tanacetum sinaicum (Asteraceae) is a rare herb growing wild in Southern Sinai mountains in Egypt. The aim of this work was to develop a comparative study between the chemical compositions of the wild plant and the micropropagated one, using HPLC− ESI− MS/MS technique. HPLC- ESI-MS/MS analysis resulted in the identification of 56 compounds including flavonoids, organic acids and their glycosides. Totally, 52 compounds were tentatively identified from the methanolic extracts of wild plant, 10 of them could also be detected in the methanolic extract of the micropropagated plant, in addition to 4 compounds that were detected only in the micropropagated plant. Methanolic extracts of the wild and micropropagated plants showed moderate cytotoxic activity against Hep-G2, HCT-116 and A-549 cell lines using MTT cell viability assay. The antioxidant activity using the DPPH free radical assay was investigated and the results indicated that the wild plant methanolic extract has better antioxidant activity compared to the in vitro plant extract. In addition, the insecticidal activity was measured using the immersion method and the methanolic extract of the micropropagated plant showed a higher mortality percentage than wild plant extract on culex pipiens. Also, results indicate that wild plant extract has mild antimicrobial activity against Gram positive bacteria Staphylococcus aureus and Bacillus subtilis and showed no activity on both fungi and Gram negative bacteria. while in vitro plant extract showed some activity against Gram positive bacteria Staphylococcus aureus and the Gram negative bacteria Escherichia coli.
- 19 June 2021
- Published by Springer Nature in Journal of Parasitic Diseases
- Vol. 46 (1) , 24-36
Efficacy of Zingiber officinale and Cinnamomum zeylanicum extracts against experimental Trichinella spiralis infection
Trichinellosis is a re-emerging zoonotic disease that has become a public health concern since its reported human outbreaks in many countries. The traditional therapy has many adverse effects in addition to the developing resistance. So, this necessitates finding effective natural alternatives. The current study targeted to assess the potential therapeutic effects of Zingiber officinale and Cinnamomum zeylanicum in comparison to albendazole, a conventional therapy for treatment of trichinosis. Sixty mice were classified into five groups (12 mice each), non-infected control, infected control, combined albendazole and prednisolone, Zingiber officinale, and Cinnamomum zeylanicum treated groups. Mice sacrifice was performed on the 7th and 35th days post infection for intestinal and muscular phases respectively. Efficiency of the used preparations was assessed by parasitological, histopathological, immunohistochemical, biochemical studies in addition to ultrastructural evaluation using transmission electron microscopy. A significant reduction in the mean number of T. spiralis adult worms and larvae was observed in Zingiber officinale and Cinnamomum zeylanicum treated groups, (64.5%, 50.8%) and (68%, 54.6%) respectively. Also, both extracts showed moderate cytoplasmic reactivity for TGF-β1, (69.3% & 67.8%) respectively. The highest reduction in serum TNF- α level was observed in Zingiber officinale treated group during the muscle phase (58.4%) while in the intestinal phase was 50%. The ultrastructural study revealed degenerative effects on both adults and larvae in addition to obvious improvement of the histopathological changes in the small intestine and muscles. We concluded that these herbal extracts especially Zingiber officinale can be considered a practical and successful alternative for the treatment of trichinellosis.
- 19 June 2021
- Published by Springer Nature in Journal of Parasitic Diseases
- Vol. 46 (1) , 24-36
Efficacy of Zingiber officinale and Cinnamomum zeylanicum extracts against experimental Trichinella spiralis infection
Trichinellosis is a re-emerging zoonotic disease that has become a public health concern since its reported human outbreaks in many countries. The traditional therapy has many adverse effects in addition to the developing resistance. So, this necessitates finding effective natural alternatives. The current study targeted to assess the potential therapeutic effects of Zingiber officinale and Cinnamomum zeylanicum in comparison to albendazole, a conventional therapy for treatment of trichinosis. Sixty mice were classified into five groups (12 mice each), non-infected control, infected control, combined albendazole and prednisolone, Zingiber officinale, and Cinnamomum zeylanicum treated groups. Mice sacrifice was performed on the 7th and 35th days post infection for intestinal and muscular phases respectively. Efficiency of the used preparations was assessed by parasitological, histopathological, immunohistochemical, biochemical studies in addition to ultrastructural evaluation using transmission electron microscopy. A significant reduction in the mean number of T. spiralis adult worms and larvae was observed in Zingiber officinale and Cinnamomum zeylanicum treated groups, (64.5%, 50.8%) and (68%, 54.6%) respectively. Also, both extracts showed moderate cytoplasmic reactivity for TGF-β1, (69.3% & 67.8%) respectively. The highest reduction in serum TNF- α level was observed in Zingiber officinale treated group during the muscle phase (58.4%) while in the intestinal phase was 50%. The ultrastructural study revealed degenerative effects on both adults and larvae in addition to obvious improvement of the histopathological changes in the small intestine and muscles. We concluded that these herbal extracts especially Zingiber officinale can be considered a practical and successful alternative for the treatment of trichinellosis.
- Open Access
HPLC-PDA-MS/MS Characterization of Bioactive Secondary Metabolites from Turraea fischeri Bark Extract and Its Antioxidant and Hepatoprotective Activities In Vivo
Turraea fischeri is an East African traditional herb, which is widely used in traditional medicine. In this study, we profiled the secondary metabolites in the methanol extract of T. fischeri bark using HPLC-PDA-ESI-MS/MS, and 20 compounds were tentatively identified. Several isomers of the flavonolignan cinchonain-I and bis-dihydroxyphenylpropanoid-substituted catechin hexosides dominated the extract. Robust in vitro and in vivo antioxidant properties were observed in 1,1-diphenyl-2-picrylhydrazyl radical scavenging assay (DPPH) and ferric reducing antioxidant power (FRAP) assay, and in the model organism Caenorhabditis elegans. Additionally, the extract exhibited promising hepatoprotective activities in D-galactosamine (D-GaIN) treated rats. A significant reduction in the elevated levels of aspartate aminotransferase (AST), total bilirubin, gamma-glutamyltransferase (GGT), and malondialdehyde (MDA) and increase of glutathione (GSH) was observed in rats treated with the bark extract in addition to D-galactosamine when compared with rats treated with D-galactosamine alone. In conclusion, T. fischeri is apromising candidate for health-promoting and for pharmaceutical applications.
Open AccessHPLC-PDA-MS/MS Characterization of Bioactive Secondary Metabolites from Turraea fischeri Bark Extract and Its Antioxidant and Hepatoprotective Activities In Vivo
Turraea fischeri is an East African traditional herb, which is widely used in traditional medicine. In this study, we profiled the secondary metabolites in the methanol extract of T. fischeri bark using HPLC-PDA-ESI-MS/MS, and 20 compounds were tentatively identified. Several isomers of the flavonolignan cinchonain-I and bis-dihydroxyphenylpropanoid-substituted catechin hexosides dominated the extract. Robust in vitro and in vivo antioxidant properties were observed in 1,1-diphenyl-2-picrylhydrazyl radical scavenging assay (DPPH) and ferric reducing antioxidant power (FRAP) assay, and in the model organism Caenorhabditis elegans. Additionally, the extract exhibited promising hepatoprotective activities in D-galactosamine (D-GaIN) treated rats. A significant reduction in the elevated levels of aspartate aminotransferase (AST), total bilirubin, gamma-glutamyltransferase (GGT), and malondialdehyde (MDA) and increase of glutathione (GSH) was observed in rats treated with the bark extract in addition to D-galactosamine when compared with rats treated with D-galactosamine alone. In conclusion, T. fischeri is apromising candidate for health-promoting and for pharmaceutical applications.